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A symposium on Human Tissue Monitoring and Specimen Banking: Opportunities for Exposure Assessment, Risk Assessment, and Epidemiologic
Research was held from 30 March to 1 April 1993 in Research Triangle Park, North Carolina. There were 1 17 registered participants from 18 states
and 5 foreign countries. The first 2 days featured 21 invited speakers from the U.S. Environmental Protection Agency, the Centers for Disease
Control and Prevention, the National Institute of Environmental Health Sciences, various other government agencies, and universities in the United
States, Canada, Germany, and Norway. The speakers provided a state-of-the-art overview of human exposure assessment techniques (especially
applications of biological markers) and their relevance to human tissue specimen banking. Issues relevant to large-scale specimen banking were dis-
cussed, including program design, sample design, data collection, tissue collection, and ethical ramifications. The final group of presentations con-
cerned practical experiences of major specimen banking and human tissue monitoring programs in the United States and Europe. The symposium
addressed the utility and research opportunities afforded by specimen banking programs for future research needs in the areas of human exposure
assessment, risk assessment, and environmental epidemiology. The third day of the symposium consisted of a small workshop convened to dis-
cuss and develop recommendations to the U.S. Environmental Protection Agency regarding applications and utility of large-scale specimen banking,
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Background
Over the last 60 years, human technologies
and activities have created and released an
unprecedented diversity and quantity of
toxic substances into the environment. As we
have learned more about the actual and
potential adverse effects ofthese pollutants
on the global ecosystem, in general, and on
human health, in particular, there has been a
growing recognition ofthe need to monitor
the release and subsequent movement of
these substances through both the physical
and biological components ofthe environ-
ment. In addition to the sampling and mon-
itoring ofthe ambient outdoor environment
for toxic pollutants, there has been an
increasing interest in both the monitoring of
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human tissues for toxic substances (1) and
the assessment oftotal human exposure to
toxic substances from all outdoor and
indoor sources (2,3). These approaches
have been further stimulated by recent sci-
entific and technical advances in the areas
ofpopulation sampling design and sam-
pling techniques, microenvironmental
monitoring, personal exposure monitoring
devices, survey instrument design, direct
quantification methods for toxic substances
or their metabolites in human tissue sam-
ples, development and use of biological
markers, and quality control and quality
assurance methodologies (4).
Biological monitoring involves the peri-
odic measurement of toxic substances or
their metabolites in samples of tissues,
secretions, excretions, or exhaled air from
biological specimens or individuals. To
serve a primary monitoring function, sam-
ple selection and collection must be
designed to be representative of a defined
target population or geographic area over a
specific time period. Biological monitoring
could thus serve an important sentinel
function in detecting the occurrence of a
widespread toxic exposure at an early stage,
before the toxic exposure becomes evident
as a widespread occurrence of adverse
health effects.
Human tissue monitoring may also
provide more accurate measurement of
internal dose for certain chemicals that
occur in relatively low concentrations in
the environment but become progressively
more concentrated along successive links of
the food chain to humans. Furthermore,
measuring toxic chemicals (or their metab-
olites) directly in the appropriate tissues of
an individual can often indicate the cumu-
lative dose of the toxic chemical over a
period of time from all possible environ-
mental pathways and routes ofentry into
the body (provided the toxic substance
remains in the tissue for a sufficiently long
period oftime). For example, most organo-
chlorine pesticides or their metabolites per-
sist in the environment and in human
tissues. Measurable amounts of many
organochlorine pesticides or their metabo-
lites were found to be ubiquitous in human
tissue samples collected from across the
United States during the 1970s (5,6).
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Similarly, during the late 1960s and early
1970s, polychlorinated biphenyls (PCBs)
were recognized as persistent environmen-
tal contaminants. Bioaccumulation of
PCBs in plants and animals resulted in
their concentration in the food chain to
humans (7) and their detection in human
tissues (8,9).
As these advances in exposure assess-
ment were occurring, the field ofenviron-
mental specimen banking was also
progressing. Environmental specimen
banking is the long-term, stable storage of
specimens sampled from the physical envi-
ronment, such as air, water, soil, or sedi-
ment samples, or of biological specimens
sampled from human, animal, or plant
populations (10). Such specimens would
be available to measure levels ofenviron-
mental pollutants (or their metabolites or
other markers of their presence) and, in
the case ofbiological specimens, to detect
and quantify biological markers ofdose or
biological response (11).
The archival collection and storage of
human tissue samples provides a unique
research opportunity for advancing the sci-
ence and technology ofhuman exposure
assessment. Banked tissue specimens col-
lected as part of national surveys could
serve as historical records ofhuman expo-
sures to toxic substances in time and space
and so could be a critical part ofa compre-
hensive program ofbiological monitoring
for toxic pollutants. Banked specimens
would be available for retrospective studies
using more sensitive, complete, or compre-
hensive analytic techniques at a later time
with the benefits of both hindsight and
more advanced technological capabilities.
Within the limitations of the sampling
frame originally designed for the collection
ofparticular specimen banks, they could,
for example, be used to measure additional
toxic substances not originally studied,
baseline values for toxic substances not
presently recognized as environmental haz-
ards, and past exposures suspected ofcaus-
ing diseases with very long latency periods.
Furthermore, specimen banks could also be
used to measure standards for assessing sta-
tus and trends in human exposure and help
evaluate the efficacy of actions taken
to prevent or reduce exposure. Large
specimen banks built from large cohort
studies provide the opportunity to design
and carry out very cost-effective nested
case-control studies (12,13).
Historically, the U.S. Environmental
Protection Agency (U.S. EPA) and a num-
ber of other government agencies have
been interested in the use ofhuman tissue
specimens and specimen banks for biologi-
cal monitoring (14). The U.S. EPA first
began serious discussion ofplans and possi-
ble proposals for a National Environmental
Specimen Banking System (NESBS) at a
conference held in 1973 at the National
Environmental Research Center in
Research Triangle Park, North Carolina.
The general objectives ofthe NESBS were
to provide short-term specimen banking to
study current trends in population body
burdens oftoxic pollutants and to provide
long-term specimen banking for future ret-
rospective studies of toxic exposures. In
1973 a workshop on the collection, long-
term storage, and utility ofenvironmental
and biological specimens was sponsored by
the National Academy of Sciences (NAS)
and the National Research Council (NRC)
at Capon Springs, West Virginia. Program
objectives were refined and formally pro-
posed at this workshop. These objectives
were to survey and evaluate current speci-
men banking efforts, to evaluate the state
of knowledge ofsample preparation and
storage methodologies, to evaluate future
research needs, and to develop a planning
document for the organization and man-
agement of a National Environmental
Specimen Bank. In December of 1973,
this proposal was jointly funded by
the U.S. EPA, the National Bureau of
Standards (NBS), and the National Science
Foundation.
In 1975, the U.S. EPA and the NBS
began a joint project to research and evalu-
ate methodologies needed to actually put a
National Environmental Specimen Bank
into operation (15). Also in 1975, the
United States and the Federal Republic of
Germany signed an agreement to jointly
research methodologies needed for the
banking ofenvironmental and biological
specimens and to establish "pilot specimen
banks" in both countries (16). These
efforts led to the establishment of a Pilot
Environmental Specimen Bank in West
Germany in 1976 and in the United States
in 1979.
From 1977 to 1982, review and evalua-
tion ofcurrent research and ongoing speci-
men banking programs were carried out at
three international workshops on biological
monitoring, exposure assessment, and speci-
men banking (17-19). These workshops
were jointly organized by the Commission
of the European Communities, the U.S.
EPA, the World Health Organization, the
Federal Environmental Agency in West
Berlin, and the Federal Ministry for
Research and Technology in Bonn,
Germany. In September of 1991, the U.S.
EPA and the German Ministry for the
Environment, Nature Protection, and
Reactor Safety cosponsored the First
International Symposium on Biological
Environmental Specimen Banking in
Vienna. This symposium dealt with
"Specimens, Sampling, Standardization, and
Storage for Monitoring and Environmental
Policy."
During this same period, there was also
a second program ofbiological monitoring
and human tissue specimen banking oper-
ating at the U.S. EPA (20). At the time of
the U.S. EPA's creation in 1970, it inher-
ited the National Human Monitoring
Program (NHMP) from the U.S. Public
Health Service. The NHMP had been
founded in 1967 as a government program
with the mission ofconducting biological
monitoring ofhuman tissue specimens for
environmental pollutants. One of the
major activities of the NHMP was the
National Human Adipose Tissue Survey
(NHATS), which was intended to be a
continuously operating survey that would
collect, store, and analyze samples of
autopsy and surgical specimens ofhuman
adipose tissue to be representative of the
major metropolitan areas ofthe country.
The NHATS was originally part of the
U.S. EPA's Office of Pesticide Programs.
In 1981, the NHATS was transferred to
the U.S. EPA's Office ofToxic Substances
and subsequently had its range of moni-
tored environmental chemicals expanded
from mainly pesticides to include other
major classes of toxic chemicals. At that
time the NHATS mission was redefined as
being to identify toxic chemicals in human
tissues, establish baseline data and trends,
and to identify any population groups with
unusually high toxic chemical exposures.
However, during the 1980s, budget cuts
decreased the activities of the NHMP to
the point at which it consisted only of a
moderately reduced version of the
NHATS. The U.S. Congress decided to
continue funding NHATS at this reduced
level until 1990, when the National
Research Council was scheduled to con-
duct a study ofthe design, needs, and util-
ity of the NHMP. That study (20)
concluded that a more comprehensive
national program of human tissue moni-
toring was a critical need, not only for the
U.S. EPA's mission to assess human expo-
sures to environmental toxins and to better
understand their health effects, but also for
evaluating the needs and effectiveness of
the U.S. EPA's regulatory programs. The
study recommended that the NHMP and
NHATS be completely redesigned to
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provide more useful data based on proba-
bility samples ofthe whole U.S. population
and that funding be increased to permit
the programs to credibly fulfill their
missions.
It was with this background and history
that the present symposium was organized
and held on 30 March to 1 April 1993 in
Research Triangle Park, North Carolina. It
was cosponsored by the University of
North Carolina School of Public Health
(UNC-SPH) and the Health Effects
Research Laboratory (HERL) of the U.S.
EPA. The Symposium Organizing Com-
mittee consisted ofscientists from UNC-
SPH (Barbara Hulka and Lester Lee),
HERL (Jack Griffith and Richard
Everson), the National Institute of
Environmental Health Sciences (George
Lucier), and the Centers for Disease
Control and Prevention (Vernon Houk).
The symposium registered 117 partici-
pants from 18 states and five foreign coun-
tries and featured 21 invited speakers from
several government agencies, including the
U.S. EPA, the Centers for Disease Control
and Prevention (CDC), and the National
Institute ofEnvironmental Health Sciences
(NIEHS), and from universities in the
United States, Canada, Germany, and
Norway. The presentations and discussions
by these invited speakers provided the basis
for the 15 papers that follow this overview.
The objectives ofthis symposium were
a) to provide a state-of-the-art overview of
human exposure assessment techniques
(especially applications of biological
marker technology) and their uses in bio-
logical monitoring; b) to review advances
in the design and implementation of
human tissue specimen banking; and c) to
synthesize and apply these techniques and
advances to the development oftissue spec-
imen banks well suited to future research
needs in the areas of human exposure
assessment, risk assessment, and environ-
mental epidemiology. The symposium pro-
gram was designed to approach these
objectives initially from a theoretical per-
spective, followed by the more practical
perspective ofoperating biological moni-
toring or specimen banking programs. The
symposium program consisted offour ses-
sions, each followed by a panel discussion
with the symposium attendees. The first
session began by addressing the opportuni-
ties that human tissue monitoring and
specimen banking offer for research and
public health practice in the areas of risk
assessment, exposure assessment, and envi-
ronmental epidemiology. The second ses-
sion included four presentations on
biological monitoring and exposure assess-
ment. The third session dealt with design
and methodological issues, including sam-
ple design and analysis, specimen collec-
tion, bank management, and ethical issues.
In the fourth session speakers presented
applications and practical experiences of
ongoing biological monitoring and speci-
men banking programs in the United
States and Europe. Finally, after the last
formal presentation of the symposium, a
small workshop was held to specifically
consider the role ofspecimen banking in
the process ofrisk assessment.
The Opportunities
The symposium opened with three presen-
tations that addressed the utility and
research opportunities afforded by biologi-
cal markers used in biological monitoring
and by specimen banking programs for
present and future research needs in the
areas of risk assessment (presented by Hal
Zenick, HERL), human exposure assess-
ment (presented by Ken Sexton, U.S.
EPA), and environmental epidemiology in
public health practice (presented by Lynn
Goldman, currently at the U.S. EPA).
Dr. Zenick began his presentation with
the observation that, while there is a multi-
tude ofbiomarkers ofexposure, effect, and
susceptibility, the number which also
meets stringent criteria ofvalidation (21),
proves to be practical in the field, and is
suitable for banked specimens is somewhat
small. Nevertheless, as this small number
grows with continuing research, the utility
of biomarkers to the risk assessment
process also grows. The use ofbiomarkers
of exposure in the exposure assessment
process is obvious and biomarkers ofeffect
may be useful in hazard identification,
especially if these indicators can be
detected at very low levels and are predic-
tive ofsubsequent adverse health effects.
Both types ofbiomarkers may be useful in
dose-response estimations ifthere is suffi-
cient understanding of the mechanistic
(pharmacokinetic) link between the bio-
marker ofexposure (indicative ofdose) and
the biomarker of effect (response).
Biomarkers could also be particularly use-
ful in making high-to-low dose extrapola-
tions and in the study of interindividual
variability.
Given the lessons learned from the
shortcomings and design flaws ofprevious
specimen banking efforts, careful definition
ofthe target population and design of the
sampling frame are essential for any speci-
men bank to be useful in risk assessment.
For example, in this context, populations
that are either highly exposed or highly
susceptible to adverse health effects of the
exposure would be of particular interest.
The utility of any specimen bank to the
risk assessment process will usually be ret-
rospective in that it could reaffirm biologi-
cal significance, predictive value, or
dose-response relationships ofbiomarkers
when their values can be compared to fol-
low-up exposure and health outcome data.
Specimen banking may also provide histor-
ical baseline data for defined populations
or help identify new high risk groups with
increased exposure or susceptibility.
Opportunities for research in human
exposure assessment were presented by Ken
Sexton in the framework ofthe U.S. EPA's
National Human Exposure Assessment
Survey (NHEXAS). The goal ofNHEXAS
is to use measurements and models to esti-
mate exposures and dosages of important
environmental pollutants in representative
samples of the whole U.S. population and
certain highly exposed or highly susceptible
subpopulations and to study causes and
trends ofexposure through time and space.
These estimates are usually based on mea-
surements ofpollutants in the immediate or
general environments ofpotentially exposed
humans; models of exposure and dose
based on contact with the pollutant and
pathways of uptake; and pharmacokinetic
models of the pollutant in the body.
Biomarkers and biological monitoring offer
the opportunity to independently study the
relationship between exposure and dose and
to compare biomarker measurements with
estimates derived from the environmental
measurements and models. Three questions
were posed as opportunities or challenges
for future research: a) How can human tis-
sue monitoring and specimen banking be
used to help us make better decisions? b)
How important is human tissue monitoring
and specimen banking compared to making
environmental measurements of a pollu-
tant? and c) How do we measure the
success ofspecimen banking efforts?
Opportunities for the use ofhuman tis-
sue monitoring and specimen banking in
environmental epidemiology and public
health practice were discussed by Lynn
Goldman in the context ofongoing public
health studies and surveillance programs,
such as cancer, birth defects, and asthma
registries. Unsatisfied surveillance needs
might well be addressed by the banking of
human tissues. Specimen banking could be
used for the monitoring oftrends in popu-
lation exposures, for the evaluation of
the efficiency ofenvironmental regulation,
as a sentinel system for exposure to new
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environmental pollutants, for the assess-
ment oflow level exposures near hazardous
waste sites, and in nested case-control stud-
ies to investigate environmental etiologies of
diseases such as childhood cancers and birth
defects. California's Department ofHealth
Services is involved in a number ofstudies
using specimen banks in a study ofchild-
hood cancers and biomarkers in a surveil-
lance system. An example ofthe latter is a
serum a-feto protein screening program
that also evaluated serum subsamples for
cotinine levels (measuring exposure to nico-
tine in tobacco smoke) for comparison to
certain birth outcome variables. Finally, a
number ofethical issues were raised such as
the duty to provide culturally sensitive and
accessible risk communications to study
populations and individuals. There is also
the issue ofenvironmental equity and the
likelihood ofhighly exposed individuals
being poor, disenfranchised, and less edu-
cated. Not only does this circumstance
make successful risk communication more
challenging, but it also indicates that early
community involvement in astudy's design,
planning, and execution is imperative.
Biological Monitoring and
Exposure Assessment
The second session focused on the use of
biological measurements in groups ofindi-
viduals or population samples to carry out
exposure assessments. Paul Lioy (Environ-
mental and Occupational Health Sciences
Institute) began this session by comparing
methods of measuring internal exposure
biomarkers to methods measuring external
markers ofexposure such as personal moni-
toring devices, microenvironmental sam-
pling, and activity pattern measurements.
The need and possibilities of integrating
these two personal monitoring approaches
in exposure assessment were illustrated using
studies ofchromium in the house dust of
people living near hazardous waste sites and
studies oflead in the blood of inner-city
children. This theme was continued in the
discussion ofseveral large studies done by
James Pirkle using biological monitoring
applications at the CDC. For example, the
reduction in blood lead levels in the U.S.
population between 1976 and 1980 dosely
paralleled the decline oflead in gasoline.
Such a dose relationship between biological
and environmental lead levels was unex-
pected because the models that had been
developed to predict the effect ofreducing
lead in gasoline had neglected a major route
ofhuman exposure to lead from gasoline-
lead in environmental dust. Dr. Pirkle also
discussed other studies where biological
monitoring data and banked human tissues
convincingly validated or invalidated a vari-
ety ofindirect methods ofexposure assess-
ment for dioxin and volatile organic
compounds undervarious studyconditions.
The use ofbiomarkers to assess dietary
exposures in epidemiologic studies was dis-
cussed by Gerald Wogan (Massachusetts
Institute of Technology). Using protein
and DNA adducts ofaflatoxin Bl, a potent
liver carcinogen, he was able to validate
their use in assessing recent dietary expo-
sure to aflatoxin in a study in Gambia. The
same molecular biomarkers were used in
China to study the interaction between
aflatoxin exposure and chronic hepatitis B
virus infection as risk factors for primary
liver cancer. The study showed that the rel-
ative risk for liver cancer associated with
aflatoxin exposure alone was 4.8 and that it
rose to 60.1 for people with both aflatoxin
exposure and chronic hepatitis B virus
infection.
The last presentation ofthis session was
given by Stephen Rappaport (UNC-SPH)
on the relationship between environmental
monitoring and biomarkers in exposure
assessment. He argued for the importance
of measuring intraindividual variation of
biomarkers and comparing it to the corre-
sponding variation in exposure experienced
by the same individual. A regression ofthe
subjects' mean biomarker values on their
mean environmental exposures would
describe the biomarker-exposure relation-
ship. A large correlation coefficient would
indicate linear pharmacokinetics, small dif-
ferences between individuals, and adequate
sample sizes of intraindividual measure-
ments, a small correlation coefficient
would indicate the opposite. He then
described a study which found that per-
sonal exposure monitoring of the subjects'
immediate environment was a better mea-
sure than a number of biomarkers for
studying the dose-response relationship.
The underlying reason for this was that the
ratio ofwithin-subject to between-subject
variance was much larger for the biomark-
ers compared to the personal monitoring
measurements.
Design and Methodological
Issues
With this session, the symposium began to
turn to more practical issues ofdesigning
studies using biological monitoring or
specimen banking. As mentioned above, a
critically important design issue for any
biological monitoring or specimen bank is
the construction of its sampling design.
Robert Murphy and Trena Ezzati-Rice,
both from the National Center for Health
Statistics, started this session by drawing
from their experience with the National
Health and Nutrition Examination Surveys
(NHANES). It is generally desirable to
have a probability sample ofthe members
of a defined target population in which
every member of the target population
(i.e., the potential sample universe) has a
known probability not equal to zero of
being sampled. Use ofprobability sampling
methods is necessary for large-scale biologi-
cal monitoring studies so that results can
be used to infer quantitatively exposures or
health effects from the probability sample
to the target population. Another impor-
tant sampling issue is that ofoversampling
special populations, such as minorities and
highly exposed or highly susceptible
groups.
Issues relating to choice ofbankable tis-
sues, intra- and interindividual variation,
and temporal variation of exposure bio-
markers were addressed by George Lucier
and Claudia Thompson, both from
NIEHS. Advances in the areas ofmolecu-
lar genetics and molecular epidemiology
now make it possible to study genetic
polymorphisms of the enzymes used to
metabolize xenobiotic compounds,
presymptomatic genetic changes (e.g.,
somatic mutations) associated with
increased risk disease, and other genetic
markers ofsusceptibility. The capability of
studying the RNA species present in tissue
samples permits researchers to study tissue-
specific gene expression. Finally, the advent
of new technologies, such as polymerase
chain reaction (PCR), now makes it possi-
ble to detect specific genotypes and specific
RNA species in extremely low concentra-
tions. PCR technology alone greatly
increases the potential ofobtainable data
from very small amounts ofbanked tissue
ofany type, as long as its preparation and
preservation conditions are compatible
with PCRanalysis.
The specific issues and technologies
concerning preparation and preservation of
tissue specimens for archival storage in a
specimen bank were presented by Elaine
Gunter, Chiefofthe NHANES Laboratory
at the National Center for Health Statistics.
She addressed issues ranging from database
management of the archived tissue and
associated data about the subject who pro-
vided the specimen, to choice of storage
container, type offreezer, and stability of
analytes of possible interest. The same
issues were examined by Stephen Wise of
the National Institute of Standards and
Technology (NIST) from the perspective
Environmental Health Perspectives 6HUMAN TISSUEMONITORINGANDSPECIMENBANKING
of quality assurance procedures used in
operating tissue specimen banks at NIST.
The session concluded with ethical
considerations raised by biomarker research
and the collection of human tissues for
specimen banks. Confidentiality issues,
informed consent, the rights of human
subjects, and the uses ofmonitoring data
in research and regulation were presented
and analyzed by Paul Schulte of the
National Institute for Occupational Safety
and Health and by Diane Wagener ofthe
National Center for Health Statistics.
Experiences with Biological
Monitoring and Specimen
Banking Programs
The fourth and final session ofthe sympo-
sium dealt with applications and practical
experiences ofongoing biological monitor-
ing and specimen banking programs in the
United States and Europe. It opened with
John Bailar of McGill University present-
ing a summary ofhis experiences chairing
the National Academy ofSciences study of
human tissue monitoring (20). Fritz
Kemper ofthe University ofMuenster gave
an overview of the operations of the
German Environmental Specimen Bank
for Human Tissue in Muenster. Egil
Jellum of the Norwegian Cancer Society
described some of the history and research
projects done at the JANUS Serum Bank
in Norway.
A study of banked biologic specimens
from about 1000 participants in NHANES
III for the biological monitoring of44 dif-
ferent environmental pollutants was pre-
sented by Larry Needham of the CDC.
Biological monitoring ofvolatile organic
compounds (VOCs) poses some special
problems because oftheir rapid rate ofloss
from the body through exhaled breath.
Lance Wallace ofthe U.S. EPA addressed
recent advances in measuring exhaled
breath and estimating exposure and body
burden for VOCs in a study involving 800
subjects. Finally, Lenore Kohlmeier ofthe
University of North Carolina School of
Public Health described a practical aspira-
tion method for sampling adipose tissue
from living subjects that had been success-
fully used in a 12-country study ofmyocar-
dial infarction, breast cancer, and dietary
antioxidants in Europe.
Workshop on Specimen
Banking and the Risk
Assessment Process
The third day ofthe symposium consisted
of a small workshop of about 20 people
discussing the specific implications of the
proceedings ofthe previous 2 days for the
process ofhuman risk assessment. The pur-
pose ofthe workshop was to develop rec-
ommendations to the U.S. EPA regarding
the application and utility of large scale
specimen banking (i.e., biological monitor-
ing and storage of tissue specimens) as it
applies to the risk assessment process at the
U.S. EPA, and other government agencies.
The group discussed the establishment ofa
National Human Tissue Bank and the
impact that such a bank would have on the
following three elements ofthe risk assess-
ment process: exposure assessment, hazard
identification, and dose-response estima-
tion. Among the group's major recommen-
dations was one that the National
Academy ofSciences should conduct a fol-
low-up study to their 1991 studyofhuman
tissue monitoring (20). This new study
would thoroughly investigate the objec-
tives, design, and management of a
National Human Tissue Bank. It was
also recommended that the National
Human Tissue Bank should be based on a
national probability sample and that it be
funded through a long-term, multiagency
mechanism.
Conclusions
Biological monitoring, exposure assess-
ment, and health effects surveillance make
up the critical parts ofthe empirical data
base necessary to understand and evaluate
the impact of environmental pollutants
upon the public health. The hierarchical
goals ofpublic health practice for the field
ofenvironmental health can be stated as:
first, to prevent unacceptable toxic expo-
sures from occurring in the first place; sec-
ond, to reduce those toxic exposures that
are judged to be unacceptable; and third, if
the first two goals fail to be met, to identify
and treat those whose health has been
damaged by the toxic exposure (22). Thus,
exposure assessment is the key measure for
evaluating the success or failure of public
health intervention programs for prevent-
ing environmentally related diseases and
for establishing associations between par-
ticular toxic exposures and those suffering
the adverse health effects that need to be
identified and treated.
Human tissue specimen banking can
play an important role in these endeavors.
Biological monitoring in connection with
specimen banking can serve a critical sen-
tinel function for environmental toxic
exposures by early identification ofspecific
toxic hazards, before toxic effects on health
become apparent. Applications ofpharma-
cokinetic data can provide a basis for the
biological interpretation ofobserved con-
centrations ofvarious environmental toxins
in body fluids and tissues.
Specimen banking mayalso serve a fun-
damental purpose in facilitating research to
establish associations between particular
toxic exposures and adverse health out-
comes. Having banked tissue specimens
available makes it possible to assay both
biomarkers ofexposure and biomarkers of
health effects in the same specimens from
the same individual. The ability to collect
this type ofdata greatly facilitates research
into establishing these associations. It also
provides data that are potentially useful to
the dose-response and exposure assessment
activities of the risk assessment process.
Finally, nested case-control study designs
can be applied to banked specimens to
investigate hypotheses concerning disease
risk factors and early biomarkers ofexpo-
sure biomarkers ofsubclinical disease as has
been done in manyhuman serum banks.
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